Expression and localization of rat aldo-keto reductases and induction of the 1B13 and 1D2 isoforms by phenolic antioxidants

Drug Metabolism and Disposition

Volumn 38, Issue 2, 2010, Pages 341-346

  MacLeod, A Kenneth ^a   Kelly, Vincent P ^b   Higgins, Larry G ^a   Kelleher, Michael O ^a   Price, Sally A ^c   Bigley, Alison L ^c   Betton, Graham R ^c   Hayes, John D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTASE ISOFORM 1A3; ALDO KETO REDUCTASE ISOFORM 1B13; ALDO KETO REDUCTASE ISOFORM 1B4; ALDO KETO REDUCTASE ISOFORM 1C9; ALDO KETO REDUCTASE ISOFORM 1D2; ALDO KETO REDUCTASE ISOFORM 7A1; ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; ETHOXYQUIN; ISOENZYME; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; BRONCHUS MUCOSA; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME LOCALIZATION; HENLE LOOP; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY PROXIMAL TUBULE; LIVER CELL NUCLEUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERTOLI CELL; SPERMATID; SPLEEN; STOMACH; TESTIS; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; BUTYLATED HYDROXYANISOLE; ETHOXYQUIN; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIVER; MALE; ORGAN SPECIFICITY; OXIDOREDUCTASES; RATS; RATS, INBRED F344; RATS, WISTAR; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RATTUS;

EID: 76149119413     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.030544     Document Type: Article

References (34)

1. Azzarello J, Fung KM, and Lin HK (2008) Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system. J Histochem Cytochem 56:853-861.
2. Bauman DR, Steckelbroeck S, and Penning TM (2004) The roles of aldo-keto reductases in steroid hormone action. Drug News Perspect 17:563-578.
3. 4-3-ketosteroid 5-β-reductase and a 3-α-hydroxysteroid dehydrogenase. Eur J Biochem 2:493-502.
4. Buller AL, Sharp RB, and Penning TM (1989) Characterization of dihydrodiol dehydrogenase in rat H-4IIe hepatoma cells. Cancer Res 49:6976-6980.
5. Ellis EM, Judah DJ, Neal GE, O'Connor T, and Hayes JD (1996) Regulation of carbonyl-reducing enzymes in rat liver by chemoprotectors. Cancer Res 56:2758-2766.
6. 1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter. Carcinogenesis 24:727-737.
7. Endo S, Matsunaga T, Mamiya H, Hara A, Kitade Y, Tajima K, and El-Kabbani O (2009) Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress. Chem Biol Interact 178:151-157.
8. Grant A, Staffas L, Mancowitz L, Kelly VP, Manson MM, DePierre JW, Hayes JD, Ellis EM, and Mancowiz L (2001) Expression of rat aldehyde reductase AKR7A1: influence of age and sex and tissue-specific inducibility. Biochem Pharmacol 62:1511-1519.
9. Hayes JD, Flanagan JU, and Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51-88.
10. Hayes JD, Judah DJ, and Neal GE (1993) Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res 53:3887-3894.
11. Hou YT, Xia W, Pawlowski JE, and Penning TM (1994) Rat dihydrodiol dehydrogenase: complexity of gene structure and tissue-specific and sexually dimorphic gene expression. Cancer Res 54:247-255.
12. Houten SM, Watanabe M, and Auwerx J (2006) Endocrine functions of bile acids. EMBO J 25:1419-1425.
13. Jin Y and Penning TM (2007) Aldo-keto reductases and bioactivation/ detoxication. Annu Rev Pharmacol Toxicol 47:263-292.
14. Jung JY, Kim YH, Cha JH, Han KH, Kim MK, Madsen KM, and Kim J (2002) Expression of aldose reductase in developing rat kidney. Am J Physiol Renal Physiol 283:F481-F491.
15. Kelly VP, Ireland LS, Ellis EM, and Hayes JD (2000) Purification from rat liver of a novel constitutively expressed member of the aldo-keto reductase 7 family that is widely distributed in extrahepatic tissues. Biochem J 348:389-400.
16. MacLeod AK, McMahon M, Plummer SM, Higgins LG, Penning TM, Igarashi K, and Hayes JD (2009) Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30:1571-1580.
17. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, and Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362-1365.
18. McCarthy TL, Hochberg RB, Labaree DC, and Centrella M (2007) 3-Ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 282:34003-34012.
19. 1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors. Biochem J 300:117-124.
20. Modica S and Moschetta A (2006) Nuclear bile acid receptor FXR as pharmacological target: are we there yet? FEBS Lett 580:5492-5499.
21. Nguyen T, Sherratt PJ, Huang HC, Yang CS, and Pickett CB (2003) Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278:4536-4541.
22. Nioi P, McMahon M, Itoh K, Yamamoto M, and Hayes JD (2003) Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J 374:337-348.
23. 4-3-ketosteroid 5β-reductase. J Biol Chem 259:7519-7524.
24. Park JH, Mangal D, Tacka KA, Quinn AM, Harvey RG, Blair IA, and Penning TM (2008) Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells. Proc Natl Acad Sci U S A 105:6846-6851.
25. Penning TM and Byrns MC (2009) Steroid hormone transforming aldo-keto reductases and cancer. Ann N Y Acad Sci 1155:33-42.
26. Perez MJ and Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15:1677-1689.
27. Primiano T, Gastel JA, Kensler TW, and Sutter TR (1996) Isolation of cDNAs representing dithiolethione-responsive genes. Carcinogenesis 17:2297-2303.
28. Qin KN and Cheng KC (1994) Structure and tissue-specific expression of the aldo-keto reductase superfamily. Biochemistry 33:3223-3228.
29. + channels altered by presence of beta-subunit. Nature 369:289-294.
30. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, and Pileri SA (1998) The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51:506-511.
31. Suzuki T, Takagi Y, Osanai H, Li L, Takeuchi M, Katoh Y, Kobayashi M, and Yamamoto M (2005) Pi class glutathione S-transferase genes are regulated by Nrf 2 through an evolutionarily conserved regulatory element in zebrafish. Biochem J 388:65-73.
32. Terubayashi H, Sato S, Nishimura C, Kador PF, and Kinoshita JH (1989) Localization of aldose and aldehyde reductase in the kidney. Kidney Int 36:843-851.
33. Zeindl-Eberhart E, Jungblut PR, Otto A, Kerler R, and Rabes HM (1997) Further characterization of a rat hepatoma-derived aldose-reductase-like protein-organ distribution and modulation in vitro. Eur J Biochem 247:792-800.
34. Zhang Y and Edwards PA (2008) FXR signaling in metabolic disease. FEBS Lett 582:10-18.